Top Institutions in Pediatric Dermatology and Allergy/Immunology
Leading institutions conduct and lead clinical trials on biologic therapies like dupilumab in pediatric populations, focusing on immunologic mechanisms of type 2 inflammation and dermatologic conditions such as CSU. Their expertise includes pediatric clinical trial design, immunology, and translational research to optimize treatment strategies for allergic and inflammatory skin diseases.
-
#1
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
NIAID leads extensive research on type 2 inflammatory pathways and biologic therapies, including clinical trials in pediatric allergic diseases such as chronic spontaneous urticaria and atopic dermatitis.
Key Differentiators
- Allergy and Immunology
- Pediatric Dermatology
- Clinical Research
-
#2
Children's Hospital of Philadelphia (CHOP)
Philadelphia, PA
CHOP has a renowned pediatric dermatology and allergy program with active involvement in clinical trials of biologics for pediatric skin diseases including CSU and atopic dermatitis.
Key Differentiators
- Pediatric Dermatology
- Pediatric Allergy and Immunology
-
#3
Massachusetts General Hospital (MGH) - Pediatric Dermatology and Immunology
Boston, MA
MGH is a leader in translational research on type 2 inflammation and biologic therapies, with strong pediatric clinical trial programs in dermatology and allergy.
Key Differentiators
- Pediatric Dermatology
- Immunology
- Clinical Trials
-
#4
Stanford University School of Medicine
Stanford, CA
Stanford has a strong focus on pediatric allergic diseases and immunologic mechanisms, contributing to clinical trials and mechanistic studies of dupilumab and related therapies.
Key Differentiators
- Pediatric Allergy and Immunology
- Dermatology
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
